Largest pharmaceuticals by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceuticals ranked by earnings, at SAR 100.5B, ahead of Eli Lilly (SAR 77.4B) and Merck & Co (SAR 68.5B). Figures as of 18 Nov 2026, 15:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonSAR 100.5B
- Median
- SAR 221.3M
- Combined market value
- SAR 19.24T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | SAR 100.5B | SAR 2.5T | SAR 1,039.51 | 0.56% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | SAR 77.4B | SAR 4.68T | SAR 5,257.76 | 0.98% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | SAR 68.5B | SAR 1.31T | SAR 530.84 | 1.29% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | SAR 57B | SAR 664.4B | SAR 150.75 | 1.25% down | 17% down | ||
| 5 | NovartisNVS · Health Care | SAR 52.5B | SAR 1.11T | SAR 590.03 | 1.15% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | SAR 38.4B | SAR 1.05T | SAR 676.72 | 1.02% down | 2% up | ||
| 7 | SanofiSNY · Health Care | SAR 32.5B | SAR 428.4B | SAR 178.40 | 0.06% up | 4% down | ||
| 8 | PfizerPFE · Health Care | SAR 29.1B | SAR 605.2B | SAR 106.17 | 0.58% down | 14% up | ||
| 9 | GSKGSK · Health Care | SAR 28.5B | SAR 369.5B | SAR 184.36 | 0.18% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | SAR 26.5B | SAR 465.1B | SAR 227.55 | 1.12% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | SAR 24.5B | SAR 681.3B | SAR 393.37 | 0.15% up | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | SAR 16.9B | SAR 373.2B | SAR 3,607.64 | 0.42% up | 36% up | ||
| 13 | AbbVieABBV · Health Care | SAR 15.9B | SAR 1.93T | SAR 1,091.45 | 0.63% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | SAR 14.8B | SAR 514.8B | SAR 2,030.41 | 1.33% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | SAR 10B | SAR 127.6B | SAR 314.11 | 0.31% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | SAR 5.3B | SAR 187.6B | SAR 160.81 | 0.59% up | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | SAR 5B | SAR 92.7B | SAR 2,177.06 | 0.63% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | SAR 3.6B | SAR 119.6B | SAR 193.93 | 0.50% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | SAR 2.9B | SAR 148.6B | SAR 258.37 | 0.29% up | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | SAR 2.6B | SAR 19B | SAR 227.39 | 0.43% up | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | SAR 1.7B | SAR 46.8B | SAR 56.17 | 1.18% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | SAR 1.7B | SAR 36.3B | SAR 239.84 | 1.96% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | SAR 1.7B | SAR 22B | SAR 32.26 | 0.35% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | SAR 1.3B | SAR 43.1B | SAR 222.47 | 1.37% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | SAR 1.2B | SAR 78.4B | SAR 585.21 | 0.31% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | SAR 1.1B | SAR 174.1B | SAR 1,524.31 | 1.67% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | SAR 906.5M | SAR 29.2B | SAR 173.88 | 1.99% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | SAR 466.8M | SAR 22.2B | SAR 1,111.72 | 0.87% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | SAR 373.8M | SAR 28.8B | SAR 262.89 | 0.02% up | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | SAR 270.3M | SAR 28.1B | SAR 80.72 | 1.89% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SAR 221.3M | SAR 28.5B | SAR 362.38 | 1.58% up | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -SAR 6.1M | SAR 23.2B | SAR 163.92 | 1.65% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -SAR 87.6M | SAR 22.5B | SAR 345.15 | 0.07% up | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -SAR 95.8M | SAR 18.3B | SAR 190.45 | 0.64% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -SAR 262.6M | SAR 20.1B | SAR 475.70 | 0.94% up | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -SAR 291.1M | SAR 24.1B | SAR 592.44 | 0.14% up | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -SAR 395.5M | SAR 24.9B | SAR 367.64 | 1.75% up | 241% up | ||
| 38 | ErascaERAS · Health Care | -SAR 467.2M | SAR 17.8B | SAR 50.81 | 2.48% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -SAR 488.2M | SAR 30.8B | SAR 472.53 | 1.05% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -SAR 582.2M | SAR 34.2B | SAR 360.02 | 2.31% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -SAR 608.9M | SAR 18.6B | SAR 329.98 | 1.14% up | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -SAR 629.4M | SAR 17.1B | SAR 155.95 | 1.11% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -SAR 687.1M | SAR 26.6B | SAR 506.39 | 0.70% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -SAR 689.4M | SAR 15.2B | SAR 110.82 | 0.56% up | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -SAR 737.2M | SAR 30.3B | SAR 436.37 | 0.24% down | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -SAR 870.2M | SAR 49.3B | SAR 98.73 | 1.82% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -SAR 949M | SAR 66.7B | SAR 1,017.46 | 0.02% up | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -SAR 1.1B | SAR 36.6B | SAR 1,576.92 | 0.38% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -SAR 1.1B | SAR 12B | SAR 61.63 | 1.99% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -SAR 1.1B | SAR 106.4B | SAR 146.81 | 1.11% up | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -SAR 1.1B | SAR 32.6B | SAR 1,166.22 | 1.92% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -SAR 1.2B | SAR 18.5B | SAR 106.34 | 1.80% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -SAR 1.3B | SAR 58.5B | SAR 910.87 | 0.88% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -SAR 1.4B | SAR 27.6B | SAR 314.95 | 2.27% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -SAR 1.4B | SAR 17.1B | SAR 102.74 | 1.59% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -SAR 2.7B | SAR 56.8B | SAR 291.68 | 1.25% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -SAR 2.9B | SAR 27.5B | SAR 197.19 | 1.78% up | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -SAR 3.6B | SAR 257.8B | SAR 80.68 | 0.60% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -SAR 4B | SAR 33.9B | SAR 42.40 | 5.93% up | 36% down | ||
| 60 | InsmedINSM · Health Care | -SAR 4.8B | SAR 100.3B | SAR 457.36 | 0.06% up | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -SAR 13.2B | SAR 89B | SAR 77.63 | 1.20% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceuticals rank first by earnings?
Johnson & Johnson (SAR 100.5B), Eli Lilly (SAR 77.4B) and Merck & Co (SAR 68.5B) are the top three of the 61 pharmaceuticals ranked by earnings as of 18 Nov 2026, 15:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by earnings.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by earnings have a combined market value of SAR 19.24T as of 18 Nov 2026, 15:06 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.